PSMA–DA1

• Description:

  PSMA–DA1 may be a useful PSMA-targeting radiotheranostic agent.

• UNSPSC:

  12352005

• Target:

  PSMA

• Type:

  Reference compound

• Related Pathways:

  Immunology/Inflammation

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/psma-da1.html

• Purity:

  98.85

• Solubility:

  DMSO : 50 mg/mL (ultrasonic)

• Smiles:

  O=C(N[C@H](C(O)=O)CCCCNC(CCCC1=CC=C(I)C=C1)=O)CCC(C(O)=O)N2CCN(CC(O)=O)CCN(CCN(CC(O)=O)CC2)C(C(O)=O)CCC(NCCCC[C@@H](C(O)=O)NC(N[C@H](C(O)=O)CCC(O)=O)=O)=O

• Molecular Formula:

  C50H76IN9O20

• Molecular Weight:

  1250.09

• References & Citations:

  [1]Iikuni S, et al. Radiotheranostics Using a Novel 225Ac-Labeled Radioligand with Improved Pharmacokinetics Targeting Prostate-Specific Membrane Antigen. J Med Chem. 2021 Sep 23;64 (18) :13429-13438.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C, 3 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  2703051-77-6